Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07897616
ABSTRACT:
The present invention relates to imidazopyridin-2-one derivatives of the formula I with the definitions specified in the description, to their pharmaceutically usable salts and to their use as medicaments.
REFERENCES:
patent: 4144341 (1979-03-01), Clark et al.
patent: WO 02/30886 (2002-04-01), None
patent: WO 2005/073199 (2005-08-01), None
patent: WO 2006/022954 (2006-03-01), None
patent: WO 2006/097808 (2006-09-01), None
patent: WO 2006/131231 (2006-12-01), None
Hcaplus 1979:145541 abstract, “Synthesis and analgesic activity of 1,3-dihydro-3-(substituted phenyl) imidazo [4,5-b]pyridines”, Clark et. al., 1978.
Follmann Markus
Muller Gunter
Petry Stefan
Tennagels Norbert
Zoller Gerhard
Davis Zinna N
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Imidazopyridin-2-one derivatives as inhibitors of lipases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridin-2-one derivatives as inhibitors of lipases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridin-2-one derivatives as inhibitors of lipases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739088